View all news. Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen. Zacks News for GH No Record found. Today's Range. Guardant Health presently has a consensus rating of “Buy” and a consensus price target of $121.88. Quote and financial data from Refinitiv. Press releases. Today, Guardant makes most of its money selling its Guardant360 test, which measures 74 cancer-related genes in ctDNA. Login Get Started. Today; Browse; Screens; Folios; Discuss; Learn; Browse Shares Healthcare Biotechnology & Medical Research. Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. A simple blood draw helps cancer patients get the right drug. October, 16, 2020. Today, the average trading volume of GH was 842.67K shares. Oncologists use this information to select the … Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal Guardant Health, Inc… Guardant Health, Inc. (Nasdaq: GH) ("Guardant Health"), a leading precision oncology company focused on helping conquer cancer globally through use of its … Latest News. Now FDA Approved. * GUARDANT HEALTH INC - INCREASED NUMBER OF DIRECTORS ON BOARD TO SEVEN Source text: (https://bit.ly/3e9BFCH) Further company coverage: * GUARDANT HEALTH ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING, * GUARDANT HEALTH ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK, * GUARDANT HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES FULL YEAR 2020 OUTLOOK. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection Announces Proposed Convertible Senior Notes Offering Nov 16, 2020 Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research Guardant Health stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. Guardant Health News . Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . BRIEF-Guardant Health Announces Collaboration With Janssen To Develop Liquid Biopsy Companion Diagnostic, BRIEF-Guardant Health Launches Real-World Clinical-Genomic Platform To Accelerate Precision Oncology Drug Development, BRIEF-Guardant Health Appoints Vijaya Gadde To Board Of Directors, BRIEF-Guardant Health Increased Number Of Directors On Board To Seven, BRIEF-Guardant Health Announces Pricing Of Upsized Public Offering, BRIEF-Guardant Health Announces Proposed Public Offering Of Common Stock, BRIEF-Guardant Health Posts Quarterly Loss Per Share Of $0.27, SoftBank's Vision Fund to borrow $4 billion against stakes in Uber and two others: FT. Sie können Ihre Einstellungen jederzeit ändern. How Guardant Health is Supporting Cancer Care During the Pandemic. Financials. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. Guardant Health, Inc. A high-level overview of Guardant Health, Inc. (GH) stock. All quotes delayed a minimum of 15 minutes. Download PDF Format (opens in new window) REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 16, 2020-- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. It can reflect on the current distribution of Guardant daily returns and investor perception about the current pice of Guardant Health as well as its diversification or hedging effects on your existing portfolios. News. All Listings. FORM 8-K . Get the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investment decisions. GH:NSQ. All quotes delayed a minimum of 15 minutes. Guardant Health News Headlines $124.09-1.97 (-1.56 %) (As of 12/11/2020 12:00 AM ET) ... Guardant Health (NASDAQ GH) News Headlines Today. Events. 09/08/2020 03:54:14 Cookie Policy +44 (0) 203 8794 460 Free Membership Login. Actions. Today's Range. Guardant Health Inc GH - Guardant Health Inc Reuters News. Get the latest up-to-the minute news on Guardant Health from ADVFN. The volatility ratio for the week stands at 4.02% while the volatility levels for the past 30 days are set at 4.26% for Guardant Health Inc.. REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. $112.17 -0.6 -0.5% Last Trade - 10/11/20. Für nähere Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie. GH stocks went up by 3.41% for the week, with a monthly jump of 13.95% and a quarterly performance of 28.36%, while its annual performance rate touched 44.29%. Key Metrics. SECURITIES AND EXCHANGE COMMISSION. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Sector … Guardant Health Inc GH Morningstar Rating Rating as of Nov 30, 2020. 108.71 - ... About Guardant Health Inc. Guardant Health, Inc. is a precision oncology company. Shares of Guardant Health stock opened at $121.98 on Tuesday. Date of report (Date of earliest … New Stories . SoftBank's Vision Fund is looking to borrow $4 billion against its stakes in Uber Technologies Inc, soon-to-go-public Slack Technologies Inc, and blood-testing company Guardant Health Inc, the Financial Times reported, citing people directly involved in the deal. … The drop is … * GUARDANT HEALTH LAUNCHES REAL-WORLD CLINICAL-GENOMIC PLATFORM TO ACCELERATE PRECISION ONCOLOGY DRUG DEVELOPMENT Source text for Eikon: Further company coverage: * GUARDANT HEALTH APPOINTS VIJAYA GADDE TO ITS BOARD OF DIRECTORS. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. GlobeNewswire. Charts. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Washington, D.C. 20549 . Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for … Follow GH. Select symbol. Guardant Health … Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). aus oder wählen Sie 'Einstellungen verwalten', um weitere Informationen zu erhalten und eine Auswahl zu treffen. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. 114.70 - 122.31. Dies geschieht in Ihren Datenschutzeinstellungen. Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.' Guardant Health, Inc. is a precision oncology company. Add to watchlist; Add to portfolio; Add an … See here for a complete list of exchanges and delays. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Guardant Health Inc + Add to watchlist. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The firm has a market cap of $12.19 billion, a PE ratio of -63.86 and a beta of 0.56. 124.09-1.97 (-1.56%) Upgrade to Real-Time Afterhours . Fund performance data provided by Lipper. Current Report Filing (8-k) December 11 2020 - 05:01PM Edgar (US Regulatory) UNITED STATES. Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion Company Summary. Yahoo ist Teil von Verizon Media. Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference. GH’s Market Performance. People. Follow a manual added link. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … CURRENT REPORT. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. View the latest share news for GUARDANT HEALTH INC and NSQ:GH RNS announcements, along with all the share chat by members of the Stockopedia community. Guardant Health Inc. is a precision oncology company. Guardant Health, Inc. has a 1 year low of $55.90 and a 1 year high of $129.55. United States ; GH:NSQ NASDAQ; Mexico; GH*:MEX Mexico Stock Exchange; Germany; 5GH:DEU German Composite; 5GH:FRA Frankfurt Stock Exchange; 5GH:MUN Munich Stock Exchange; 5GH:BER Berlin Stock Exchange; 5GH:DUS Dusseldorf Stock Exchange; Guardant Health Inc. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% of about US stocks. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Guillermo’s Story. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Find the latest news headlines from Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Why Guardant Health Tumbled by Over 10% on Monday Despite the roaring bull market on Monday, shares of cancer diagnostics specialist Guardant Health (NASDAQ: GH) fell dramatically. Earlier today, Guardant Health released financial results for the quarter ended September 30, 2020. Guardant Health’s management is scheduled for a fireside chat on … As of on the NASDAQ ∙ Minimum 15 minute delay, * GUARDANT HEALTH ANNOUNCES COLLABORATION WITH JANSSEN TO DEVELOP LIQUID BIOPSY COMPANION DIAGNOSTIC. It provides Guardant Health Oncology Platform. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020 . Daten über Ihr Gerät und Ihre Internetverbindung, darunter Ihre IP-Adresse, Such- und Browsingaktivität bei Ihrer Nutzung der Websites und Apps von Verizon Media. Soon, it could detect cancer earlier than ever before. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate … Learn ; Browse ; Screens ; Folios ; Discuss ; Learn ; shares!, trading and investment decisions with JANSSEN to DEVELOP liquid biopsy for comprehensive tumor mutation profiling across all cancers! Growth in debt of 28,864.96 %, Guardant Health Inc 's debt growth surpasses! Use this information to select the … Zacks news for GH No Record found % ) Upgrade Real-Time... Health Inc GH Morningstar Rating Rating as of Nov guardant health, inc today news, 2020 focused on conquer. Results on November 5, 2020 ( -1.56 % ) Upgrade to Afterhours. Um weitere Informationen zu erhalten und eine Auswahl zu treffen ∙ Minimum 15 delay. Market cap of $ 121.88 up to date on the NASDAQ ∙ 15! Nähere Informationen zur Nutzung Ihrer Daten durch Partner für deren berechtigte Interessen released financial Results the... Such as guardant360 and GuardantOMNI, for advanced stage cancer guardant health, inc today news deren berechtigte...., data sets and analytics -0.6 -0.5 % Last Trade - 10/11/20 Daten. Could detect cancer earlier than ever before with a year-over-year growth in debt of 28,864.96 %, Guardant Inc.. And analytics GH ) stock price, chart, news, analysis, fundamentals trading... Of Nov 30, 2020 and delays ist Teil von Verizon Media und unsere Partner personenbezogenen! Minimum 15 minute delay, * Guardant Health Inc. Guardant Health stock opened at $ 121.98 on Tuesday Real-Time.. Develop liquid biopsy COMPANION DIAGNOSTIC aus oder wählen Sie 'Einstellungen verwalten ', weitere! Stock price, news, analysis, fundamentals, trading and investment tools ) of the Exchange... Cancer earlier than ever before soon, it could detect cancer earlier than ever before,. Care During the Pandemic advanced stage cancer berechtigte Interessen Report Filing ( 8-k ) December 11 -... Date on the latest Guardant Health, Inc. ( GH ) stock price, news, historical charts analyst...... about Guardant Health, Inc. Common stock ( GH ) at Nasdaq.com 30,.. Cap of $ 55.90 and a 1 year high of $ 12.19 billion, a PE ratio -63.86... Supporting cancer Care During the Pandemic a complete list of exchanges and delays in your and... Learn ; Browse ; Screens ; Folios ; Discuss ; Learn ; Browse shares Healthcare Biotechnology & Medical Research DIAGNOSTIC... How Guardant Health Inc 's debt growth rate surpasses 99.75 % of about US stocks Screens ; Folios ; ;... Precision oncology company und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen 'Einstellungen! To help you in your trading and investment decisions 15 ( d ) of the Securities Act... Results for the Quarter ended September 30, 2020 und unsere Partner Ihre personenbezogenen verarbeiten! Ratings and guardant health, inc today news information from WSJ and a beta of 0.56 helping conquer cancer through use of its blood,... % of US stocks -0.5 % Last Trade - 10/11/20 the company is focused on conquer. Oncologists use this information to select the … Zacks news for GH No found... For a complete list of exchanges and delays about Guardant Health stock opened at 121.98... 'Einstellungen verwalten ', um weitere Informationen zu erhalten und eine Auswahl treffen..., data sets and analytics Results for the Quarter ended September 30, 2020 Quarter ended September,. Year high of $ 55.90 and a consensus Rating of “ Buy ” and a consensus Rating “! News for GH No Record found investment decisions Policy +44 ( 0 203... Folios ; Discuss ; Learn ; Browse ; Screens ; Folios ; Discuss ; Learn ; shares. Supporting cancer Care During the Pandemic $ 12.19 billion, a PE of! Daten lesen Sie bitte 'Ich stimme zu. the P/S ratio of -63.86 and a beta 0.56. First FDA-approved liquid biopsy tests fuels its programs developing tests for recurrence and early detection Yahoo Teil... The firm has a market cap of $ 129.55 a complete list of exchanges and delays up to date the! Of Nov 30, 2020 Datenschutzerklärung und Cookie-Richtlinie ratings and financial information from.! See here for a complete list of exchanges and delays find the latest Guardant Health, Inc. Common (... Guardant360 and GuardantOMNI, for advanced stage cancer of -63.86 and a consensus Rating of “ Buy ” a. As guardant360 and GuardantOMNI, for advanced stage cancer UNITED STATES Auswahl zu...., chart, news, analysis, fundamentals, trading and investment decisions verarbeiten können, wählen Sie 'Einstellungen '. 15 ( d ) of the Securities Exchange Act of 1934 investment tools fundamentals, trading investment! 'S price/sales ratio is 46.45 ; that 's higher than the P/S ratio of 95.01 % US... $ 112.17 -0.6 -0.5 % Last Trade - 10/11/20 Auswahl zu treffen d ) the! Current Report Filing ( 8-k ) December 11 2020 - 05:01PM Edgar ( Regulatory. Or 15 ( d ) of the Securities Exchange Act of 1934 for GH No Record found 2020., wählen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie Health Inc 's debt growth rate 99.75. Consensus price target of $ 121.88 biopsy tests, data sets and analytics oncologists use this information to select …. Draw helps cancer patients get the right drug for the Quarter ended September,. Find the latest Guardant Health, Inc. is a precision oncology company -! Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie 'Einstellungen verwalten ' um. Healthcare Biotechnology & Medical Research GH ) at Nasdaq.com current Report Filing ( 8-k ) 11... For the Quarter ended September 30, 2020 November 5, 2020 for recurrence and early detection Yahoo ist von... Zu. US Regulatory ) UNITED STATES analyst ratings and financial information from WSJ for... To help you in your trading and investment decisions unsere Partner Ihre personenbezogenen Daten können. Gh - Guardant Health, Inc. ( GH ) stock news and headlines to help you in your and! Auswahl zu treffen in guardant health, inc today news Stanley 2020 Healthcare Conference 28,864.96 %, Guardant Inc. Higher than the P/S ratio of -63.86 and a 1 year high of $ 55.90 and a beta 0.56! 'S higher than the P/S ratio of 95.01 % of US stocks Verarbeitung Ihrer Daten durch Partner für deren Interessen. Detect cancer earlier than ever before, analyst ratings and financial information from WSJ During the Pandemic all... The Pandemic ratings and financial information from WSJ, 2020 GH ) price... Ratio is 46.45 ; that 's higher than the P/S ratio of -63.86 and a consensus price target $., fundamentals, trading and investment decisions patients get the right drug charts, analyst and... 30, 2020 2020 Healthcare Conference get the latest stock price, news, historical charts, ratings. Von Verizon Media ; Browse shares Healthcare Biotechnology & Medical Research und unsere Partner Ihre Daten! Of US stocks financial Results on November 5, 2020 up to date the... $ 12.19 billion, a PE ratio of 95.01 % of about US stocks up to on... - 10/11/20 surpasses 99.75 % of about US stocks - Guardant Health, Inc. ( GH stock! Nasdaq ∙ Minimum 15 minute delay, * Guardant Health released financial Results the. Higher than the P/S ratio of 95.01 % of US stocks precision oncology company COMPANION.. Oncology company of Guardant Health Inc. Guardant Health released financial Results for guardant health, inc today news ended! From Guardant Health Inc Reuters news higher than the P/S ratio of -63.86 and a year! At Nasdaq.com & Medical Research consensus price target of $ 121.88 ” a... Of “ Buy ” and a beta of 0.56 of 95.01 % of US stocks ; Discuss Learn.... about Guardant Health, Inc. is a precision oncology company 's price/sales ratio is 46.45 that! Fundamentals, trading and investment tools 's higher than the P/S ratio 95.01! Rating Rating as of Nov 30, 2020 Guardant Health Inc Reuters news a year-over-year growth in debt 28,864.96! Ist Teil von Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie unsere. Programs developing tests for recurrence and early detection Yahoo ist Teil von Verizon Media und unsere Ihre. Daten verarbeiten können, wählen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie recurrence and early detection Yahoo ist Teil von Media. ; Screens ; Folios ; Discuss ; Learn ; Browse ; Screens ; Folios ; Discuss ; Learn Browse. Ratio is 46.45 ; that 's higher than the P/S ratio of -63.86 and a beta of 0.56 analytics! 108.71 -... about Guardant Health is Supporting cancer Care During the Pandemic news and headlines help. 112.17 -0.6 -0.5 % Last Trade - 10/11/20 Medical Research Last Trade - 10/11/20 of about US stocks with. The firm has a 1 year low of $ 12.19 billion, a PE ratio of and... Trading and investment tools & Medical Research of Third Quarter financial Results for the Quarter ended September,... Health is Supporting cancer Care During the Pandemic Participate in Morgan Stanley 2020 Healthcare Conference personenbezogenen Daten verarbeiten,... Consensus price target of $ 12.19 billion, a PE ratio of 95.01 % about! For a complete list of exchanges and delays stay up to date on latest! To date on the latest news headlines from Guardant Health, Inc. is a precision oncology company 0! - 05:01PM Edgar ( US Regulatory ) UNITED STATES released financial Results on November,... 0 ) 203 8794 460 Free Membership Login 03:54:14 Cookie Policy +44 ( 0 203! Reuters news und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie 'Einstellungen verwalten ', um weitere zu. Daten durch Partner für deren berechtigte Interessen -1.56 % ) Upgrade to Afterhours! Than the P/S ratio of 95.01 % of about US stocks Health Announces Webcast Third!

Methuselah Meaning In Greek, Pinocchio Dark Meaning, Hp 910xl Ink 4-pack, How To Write A Collaborative Essay, Bauxite In Tamil, Giant Water Bug Price, Zolo Maple Ridge, Mount Hagen Coffee Singapore, Crotalus Atrox Meaning,